According to Reviva’s scientific director, Dr. Norman Makdissi, Reviva will be the only medical facility in the Middle East equipped to collect, process, preserve and transplant stem cells from four different tissue sources in patients from Lebanon and abroad.
You are here
Coverage of the latest news and updates from the field of stem cells.
The Forbes article, by medical reporter Larry Husten, discusses a paper published in the International Journal of Cardiology in which Darrel Francis, of the National Heart and Lung Institute, Imperial College London, UK, and several colleagues scrutinize 48 papers from the resea
While their liver might not yet be ready to treat patients — that might be as far as a decade down the road, the co-investigators in this landmark study predict — they say their work provides proof of concept for more ambitious organ-growing experiments.
The Max Planck Society’s Senate named Dr. Stratmann to the 2014–2020 term of office at its General Meeting on June 6 in Potsdam. The 59-year-old chemist is currently serving as director of the Max-Planck-Institute for Iron Research in Düsseldorf. He will take over the position from Dr.
Researchers at New York University’s Langone Medical Center have used genetically engineered mice to document for the first time the biochemical chain of events that unfolds in the wake of a fingertip amputation.
The European Court ruled last year that no patents can be granted for any technique based on human embryonic stem cells because it involved the destruction of something “capable of commencing the process of development of a human being.” The ban also included pre-established cell lines and invent
These findings provide a platform for future development of patient-specific stem/progenitor cells and more differentiated blood products for cell-replacement therapy.
A clinical hold is an order issued by the FDA to delay a proposed clinical investigation or to suspend an ongoing investigation. Once the applicant has submitted a complete response to the clinical hold, the FDA must evaluate the response and decide whether to lift the hold.
“We found that not only can we make adult cells, but also placenta,” said DanStem’s Josh Brickman, PhD., who led the study. “In fact we got precursors of placenta, yolk sac as well as embryo, from just one cell.”
Habib Zaghouani, Ph.D., led the research team at the University of Missouri School of Medicine. "We discovered that Type 1 diabetes destroys not only insulin-producing cells but also blood vessels that support them," he said.